Dr Amna Sheri is a Consultant Medical Oncologist based in London, specialising in the management of breast cancer and melanoma. She is affiliated with the Royal Free Hospital, where she has been serving since her appointment in 2015. Dr Sheri is highly skilled in administering systemic therapies for both early and advanced stages of breast cancer, including adjuvant therapy, neo-adjuvant therapy, immunotherapy, and treatment of secondary breast cancer. She also has expertise in novel biological and targeted therapies, particularly for young women with breast cancer.

Dr Sheri graduated from Imperial College London in 2004 and subsequently trained in Medical Oncology at the Royal Marsden Hospital. She was awarded an MD research degree from the Institute of Cancer Research for her pioneering work on predicting outcomes following neo-adjuvant therapy. Her research primarily focuses on the use of prognostic and predictive biomarkers in early breast cancer, and she has published extensively in peer-reviewed journals. Dr Sheri has also presented her findings at numerous national and international conferences.

In her clinical practice, Dr Sheri offers a range of treatments including biological therapy, chemotherapy, hormone therapy, and targeted therapy. She is actively involved in clinical trials, aiming to advance the understanding and treatment of breast cancer and melanoma. Her areas of interest include breast cancer in young women and pregnancy-associated breast cancer.

Dr Sheri's commitment to research and patient care makes her a leading figure in the field of medical oncology. Her contributions continue to shape the future of cancer treatment, providing hope and improved outcomes for her patients.